TY - JOUR
T1 - Diffuse esophageal uptake on 18F-fluorodeoxyglucosepositron emission tomography/computed tomography scan
AU - Shephard, Christopher James
AU - Wang, William Jiaen
AU - Baran, Bulent
PY - 2025
Y1 - 2025
N2 - A 54-year-old male with stage IV non-small-cell lung adenocarcinoma receiving maintenance pembrolizumab was evaluated for symptoms of oral ulceration, dysphagia/odynophagia and unintentional weight loss over 1 month. Examination of the oral mucosa was pertinent for oral candidiasis.
AB - A 54-year-old male with stage IV non-small-cell lung adenocarcinoma receiving maintenance pembrolizumab was evaluated for symptoms of oral ulceration, dysphagia/odynophagia and unintentional weight loss over 1 month. Examination of the oral mucosa was pertinent for oral candidiasis.
UR - http://www.scopus.com/inward/record.url?scp=105004430690&partnerID=8YFLogxK
UR - https://go.openathens.net/redirector/westernsydney.edu.au?url=https://www.clinicalkey.com.au/#!/content/journal/1-s2.0-S1542356525001624
U2 - 10.1016/j.cgh.2025.02.003
DO - 10.1016/j.cgh.2025.02.003
M3 - Article
C2 - 40081633
AN - SCOPUS:105004430690
SN - 1542-3565
JO - Clinical Gastroenterology and Hepatology
JF - Clinical Gastroenterology and Hepatology
ER -